详情页 - 四川省肿瘤医院知识库

资源类型：

文章类型：

作者：

Lyu, Fangfang[1] * ; Cao, Junning[2] ; Wang, Tingyu[3,4] ; Sun, Xiuhua[5] ; Qiu, Lihua[6] ; Su, Hang[7] ; Li, Zhiming[8] ; Song, Yuqin[9] ; Zhang, Li[10] ; Li, Dengju[11] ; Wu, Huijing[12] ; Zhang, Wei[13] ; Li, Junmin[14] ; Zhou, Keshu[15] ; Zhou, Hui[16] ; Yang, Yu[17] ; Li, Zhifeng[18,19] ; Cen, Hong[20] ; Cai, Zhen[21] ; Zhang, Zhihui[22]

; Fu, Weijun[23] ; Jie, Jin[24] ; Li, Fei[25] ; Wu, Weixin[26] ; Gu, Xuekui[27] ; Zhu, Weiliang[28] ; Liu, Lihong[29] ; Li, Zengjun[30] ; Yi, Shuhua[3,4] ; Bao, Hanying[31] ; Xu, Zusheng[31] ; Qiu, Lugui[3,4] ;

机构： [1]Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China [2]Fudan Univ, Shanghai Canc Ctr, Dept Lymphoma, Shanghai, Peoples R China [3]Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Haihe Lab Cell Ecosyst, State Key Lab Expt Hematol,Natl Clin Res Ctr Bloo, Tianjin, Peoples R China [4]Tianjin Inst Hlth Sci, Tianjin, Peoples R China [5]Dalian Med Univ, Hosp 2, Dalian, Peoples R China [6]Tianjin Med Univ, Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Tianjins Clin Res Ctr Canc,Key Lab Canc Prevent &, Tianjin, Peoples R China [7]Acad Mil Med Sci, Hosp Affiliated 307, Beijing, Peoples R China [8]Sun Yat sen Univ, Ctr Canc, State Key Lab Oncol South China, Dept Med Oncol,Collaborat Innovat Ctr Canc Med, Guangzhou, Peoples R China [9]Peking Univ Canc Hosp & Inst, Minist Educ, Dept Lymphoma, Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China [10]Sichuan Univ, West China Hosp, Chengdu, Peoples R China [11]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Hematol, Wuhan, Peoples R China [12]Hubei Canc Hosp, Wuhan, Peoples R China [13]Chinese Acad Med Sci & Peking Union Med Coll, Dept Hematol, Beijing, Peoples R China [14]Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai, Peoples R China [15]Zhengzhou Univ, Henan Canc Hosp, Canc Hosp, Dept Hematol, Zhengzhou, Peoples R China [16]Cent South Univ, Xiangya Sch Med, Canc Hosp, Hunan Canc Hosp, Changsha, Peoples R China [17]Fujian Med Univ, Tumor Hosp, Fujian Prov Canc Hosp, Fuzhou, Peoples R China [18]Xiamen Univ, Affiliated Hosp, Dept Hematol 1, Xiamen, Peoples R China [19]Xiamen Univ, Sch Med, Inst Hematol, Xiamen, Peoples R China [20]Guangxi Med Univ, Tumor Hosp, Nanning, Peoples R China [21]Zhejiang Univ, Sch Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou, Peoples R China [22]Sichuan Canc Hosp & Inst, Chengdu, Peoples R China [23]Tongji Univ, Sch Med, Shanghai Peoples Hosp 4, Shanghai, Peoples R China [24]Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou, Peoples R China [25]Nanchang Univ, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China [26]Xiamen Univ, Zhongshan Hosp, Xiamen, Peoples R China [27]Guangzhou Univ Chinese Med, Affiliated Hosp 1, Dept Hematol, Guangzhou, Peoples R China [28]Southern Med Univ, Zhujiang Hosp, Guangzhou, Peoples R China [29]Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China [30]Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Tianjin, Peoples R China [31]Shanghai Yingli Pharmaceut Co Ltd, Shanghai, Peoples R China

出处：

DOI：

ISSN：

语种：

WOS：

中科院(CAS)分区：

出版当年[2023]版：

大类 | 1 区

医学

小类 | 1 区血液学

最新[2023]版：

大类 | 1 区

医学

小类 | 1 区血液学

JCR分区：

出版当年[2023]版：

Q1 HEMATOLOGY

最新[2023]版：

Q1 HEMATOLOGY

第一作者：

第一作者机构： [1]Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

Dose Adjustments of Linperlisib in Relapsed or Refractory Follicular Lymphoma: A Post-Hoc Analysis of a Pivotal Phase II Study

文献详情